Insulet Corporation (PODD): Among the Best Diabetes Stocks to Buy According to Billionaires
We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...
Nasdaq16d
RBC Capital Initiates Coverage of Insulet (PODD) with Outperform Recommendation
The firm increased its portfolio allocation in PODD by 6.31% over the last quarter. AMCPX - AMCAP FUND holds 3,225K shares representing 4.59% ownership of the company. In its prior filing ...
Nasdaq26d
Compared to Estimates, Insulet (PODD) Q4 Earnings: A Look at Key Metrics
Insulet (PODD) reported $597.5 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 17.2%. EPS of $1.15 for the same period compares to $1.40 a year ago.